C18H21NO3, monoclinic, .P1211 (no. 4), a = 14.169(7) Å, b=8.533(4)Å,c=19.86(1)Å,β=104. 79(2)°, V= 2322.0 Å3,Z= 6, Rgt(F) = 0.045, wRref(F2) = 0.164, T= 100 K. © by Oldenbourg Wissenschaftsverlag
C20H21N04, monoclinic, P121/cl (No. 14), a = 7.521(2) Å,b = 23.257(2) Å c = 9.784(2) &Ar...
C16H15NO, monoclinic, P121/a1 (No. 14), a = 7.085(1) Å, b = 18.587(3) Å, c = 9.080(2) Å, β = 95.30(2...
C15H24O3, orthorhombic, P212121 (no. 19), a = 7.5352(2) Å, b = 10.6639(3) Å, c = 17.5406(5) Å, V = 1...
C18H21NO3, monoclinic, P121l (no. 4), a = 14.169(7) Å, b = 8.533(4) Å, c = 19.86(1) Å, β= 104.79(2)°...
C13H13NO3, monoclinic, C2/c (no. 15), a = 22.886(3) Å, b = 12.763(2) Å, c = 8.175(1) Å, β = 107.756(...
C18H19NO3, monoclinic, P121/n1 (No. 14), a = 8.454(6) Å, b= 13.123(3) Å, c = 14.698(3) Å,ß= 104.85(3...
C17H13NO2, monoclinic. P1211 (No. 4), a = 5.0336(5) Å, b = 13.964(2) Å, c = 9.025(2)Å,β = 98.56(1)°,...
CHNO, monoclinic, P12/n1 (No. 14), a = 8.454(6) Å, b= 13.123(3) Å, c = 14.698(3) Å,ß= 104.85(3)°, V=...
The title compound was prepared by cyclization of 2-(3,4-methylenedioxyphenyl)ethyl-3-hydroxyisoindo...
The title compound was prepared by cyclization of 2-(3,4-methylenedioxyphenyl)ethyl-3-hydroxyisoindo...
C16H15NO, monoclinic, P121/a1 (No. 14), a = 7.085(1) Å, b = 18.587(3) Å, c = 9.080(2) Å, β = 95.30(2...
C20H21NO4, monoclinic, P121/c1 (No. 14), a = 7.521(2) Å, b = 23.257(2) Å, c = 9.784(2) Å,ß = 95.57(2...
CHNO, monoclinic, P12/c1 (No. 14), a = 7.521(2) Å, b = 23.257(2) Å, c = 9.784(2) Å,ß = 95.57(2)°, V=...
C19H18N4O, monoclinic, P21/c (no. 14), a = 11.3744(16) Å, b = 13.7367(15) Å, c = 11.208(2) Å, β = 11...
C15H16N4O, monoclinic, P21/c (no. 14), a = 10.3021(8) Å, b = 15.7835(13) Å, c = 8.3052(7) Å, β = 90....
C20H21N04, monoclinic, P121/cl (No. 14), a = 7.521(2) Å,b = 23.257(2) Å c = 9.784(2) &Ar...
C16H15NO, monoclinic, P121/a1 (No. 14), a = 7.085(1) Å, b = 18.587(3) Å, c = 9.080(2) Å, β = 95.30(2...
C15H24O3, orthorhombic, P212121 (no. 19), a = 7.5352(2) Å, b = 10.6639(3) Å, c = 17.5406(5) Å, V = 1...
C18H21NO3, monoclinic, P121l (no. 4), a = 14.169(7) Å, b = 8.533(4) Å, c = 19.86(1) Å, β= 104.79(2)°...
C13H13NO3, monoclinic, C2/c (no. 15), a = 22.886(3) Å, b = 12.763(2) Å, c = 8.175(1) Å, β = 107.756(...
C18H19NO3, monoclinic, P121/n1 (No. 14), a = 8.454(6) Å, b= 13.123(3) Å, c = 14.698(3) Å,ß= 104.85(3...
C17H13NO2, monoclinic. P1211 (No. 4), a = 5.0336(5) Å, b = 13.964(2) Å, c = 9.025(2)Å,β = 98.56(1)°,...
CHNO, monoclinic, P12/n1 (No. 14), a = 8.454(6) Å, b= 13.123(3) Å, c = 14.698(3) Å,ß= 104.85(3)°, V=...
The title compound was prepared by cyclization of 2-(3,4-methylenedioxyphenyl)ethyl-3-hydroxyisoindo...
The title compound was prepared by cyclization of 2-(3,4-methylenedioxyphenyl)ethyl-3-hydroxyisoindo...
C16H15NO, monoclinic, P121/a1 (No. 14), a = 7.085(1) Å, b = 18.587(3) Å, c = 9.080(2) Å, β = 95.30(2...
C20H21NO4, monoclinic, P121/c1 (No. 14), a = 7.521(2) Å, b = 23.257(2) Å, c = 9.784(2) Å,ß = 95.57(2...
CHNO, monoclinic, P12/c1 (No. 14), a = 7.521(2) Å, b = 23.257(2) Å, c = 9.784(2) Å,ß = 95.57(2)°, V=...
C19H18N4O, monoclinic, P21/c (no. 14), a = 11.3744(16) Å, b = 13.7367(15) Å, c = 11.208(2) Å, β = 11...
C15H16N4O, monoclinic, P21/c (no. 14), a = 10.3021(8) Å, b = 15.7835(13) Å, c = 8.3052(7) Å, β = 90....
C20H21N04, monoclinic, P121/cl (No. 14), a = 7.521(2) Å,b = 23.257(2) Å c = 9.784(2) &Ar...
C16H15NO, monoclinic, P121/a1 (No. 14), a = 7.085(1) Å, b = 18.587(3) Å, c = 9.080(2) Å, β = 95.30(2...
C15H24O3, orthorhombic, P212121 (no. 19), a = 7.5352(2) Å, b = 10.6639(3) Å, c = 17.5406(5) Å, V = 1...
DOI
Add to ORKG